168 filings
Page 5 of 9
6-K
31t7het0
8 Feb 22
CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO
6:34am
6-K
bxiiuw p7r
3 Feb 22
Current report (foreign)
6:03am
6-K
c47t4q8op78w 0l
1 Feb 22
CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan
9:30am
6-K
jfdb wsckvlp866pod
20 Jan 22
Current report (foreign)
7:03am
6-K
blge 52e2
4 Jan 22
Current report (foreign)
7:57am
6-K
24k153xspqiclpd
20 Dec 21
CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Veteran Kim Stratton Appointed as Interim CEO
8:30am
6-K
wlmmu56rydp jh
24 Nov 21
CENTOGENE Reports Third Quarter 2021 Financial Results
7:41am
6-K
10qn5du vzejis
18 Nov 21
Current report (foreign)
8:05am
6-K
sfm8uw
4 Nov 21
CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases
6:30am
6-K
e0ef2e1lr2wz
28 Oct 21
Current report (foreign)
6:26am
6-K
ktbsf citbpjzkqx6
6 Oct 21
CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
8:10am
6-K
hfd0hc6 zjmp
7 Sep 21
CENTOGENE Reports Second Quarter 2021 Financial Results
6:20am
6-K
o1sszewby6hkiwg8do7
1 Sep 21
Current report (foreign)
6:30am
6-K
pg78el7e6c
27 Jul 21
Current report (foreign)
6:36am
6-K
tuffz
25 Jun 21
CENTOGENE Announces Shareholders Approve All Resolutions at Annual General Meeting
6:30am
6-K
x5pwxdn37q81l9myo1wb
22 Jun 21
CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Next 10 Years
6:30am
6-K
6fjggvi
16 Jun 21
CENTOGENE Reports First Quarter 2021 Financial Results in the Lead Up to
6:54am
6-K
svixgc 5dtlll
9 Jun 21
Current report (foreign)
4:35pm
6-K
0ou9e63oxurk
8 Jun 21
Current report (foreign)
6:31am
6-K
74cpekv
7 Jun 21
CENTOGENE Announces Virtual Investor Event
6:11am